MedTrace Logo

Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function

NCT03331432 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-02-19

No results posted yet for this study

Summary

The purpose of the present study is to determine if use of dietary supplement tauroursodeoxycholic acid enhances insulin-stimulated leg blood flow and glucose disposal.

Conditions

Interventions

DIETARY_SUPPLEMENT

Tauroursodeoxycholic acid

Taking tauroursodeoxycholic acid (1750 mg/day) capsules for 4 weeks.

DIETARY_SUPPLEMENT

Placebo

Taking daily placebo capsules for 4 weeks.

Sponsors & Collaborators

  • University of Missouri-Columbia

    lead OTHER

Principal Investigators

  • Jaume Padilla, PhD · University of Missouri-Columbia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-28
Primary Completion
2017-08-15
Completion
2018-02-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03331432 on ClinicalTrials.gov